Kidneys

Plasma biomarkers may accurately identify patients with low risk for kidney function loss after acute kidney injury

Alternate lab test shows comparable accuracy, non-biased results, finds NIH-supported study

 Researchers gain insight into how solid tumor cancers spread

AACC has issued a new guidance with the latest best practices for diagnosing and managing AKI

A new noninvasive test demonstrates potential to diagnose kidney allograft rejection

The biomarkers could help discriminate treatment-associated kidney injury from other causes, guiding treatment

Researchers recently discovered that two key proteins have opposite roles than what was previously believed

This unique product is intended for the calibration, or calibration verification, of total protein and albumin concentrations in both urine and cerebral spinal fluid

Dana-Farber Cancer Institute scientists have identified several features of kidney cancer tumors that influence their response to immune checkpoint inhibitor drugs

Researchers discover non-invasive method to visualize damage in donor kidneys—empowering doctors to match kidney quality with patient life expectancy for longer-lasting transplantation outcomes